% | $
Quotes you view appear here for quick access.

Trius Therapeutics, AŞ Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • beavertail_splash beavertail_splash Jan 25, 2013 4:28 AM Flag


    John Eastman's Seeking Alpo article "inherent risk is that if by chance new Phase III data is not positive, raising funds now is smarter and trying to do so after negative news is out. There is no indication of anything negative at this time and since the trial is blinded, management has no information that effect" ( hope that pop 8 days ago followed by dilution last week wasn't a blind test leak)
    Bayer kicks in another $50mil apon approval. Buyout hype & EMA will have to keep this buoyant till then